MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
T Cell Therapy

EBV-Specific T Cell Therapy for Progressive MS

MStranslate
November 20, 2018
Epstein-Barr virus, Infection, Progressive MS, Research, Treatments
Research Summary: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Last week, during our Facebook Live Q&A, we discussed the potential role of Epstein-Barr Virus or EBV in...
Gut Microbiome

ECTRIMS 2018: The Gut Microbiome in MS

MStranslate
November 19, 2018
Conferences, ECTRIMS, Research
1 Comment
"It is intriguing...can you modulate the gut microbiome to improve outcomes in MS, such as reducing relapse rates? That would be a fabulous end goal!" - Prof Helen Tremlett. The potential role of the gut...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 3

MStranslate
October 18, 2018
Conferences, ECTRIMS, Research
1 Comment
This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 2

MStranslate
October 15, 2018
Conferences, ECTRIMS, Research
2 Comments
This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 1

MStranslate
October 11, 2018
Conferences, ECTRIMS, Research
2 Comments
This year, MStranslate has invested in travelling to the ECTRIMS Congress 2018, recognising it's the easiest and most efficient way to inform our online communities of the important insights and outcomes being...
ibudilast

Ibudilast Phase 2 Trial Results for Progressive MS

MStranslate
August 30, 2018
Progressive MS, Research, Treatments
Research Summary: Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis What is it? Ibudilast is an anti-inflammatory treatment, which also has effects that protect nerves.  It is thought to offer...
heart disease

Heart Disease Linked To Brain Atrophy In MS

MStranslate
August 15, 2018
Basic Sciences, Lifestyle, Research
2 Comments
Research Summary:  Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study WHO? This study was performed by researchers at the...
primary progressive MS research

Primary Progressive MS Research: Treatment Outcomes

MStranslate
August 9, 2018
Progressive MS, Research, Treatments
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS Primary progressive multiple sclerosis (PPMS) is characterised by a steady worsening of disease or accumulation of disability from onset without any lengthy periods of...
blood platelets

Inflammation in the CNS is driven by platelets

MStranslate
July 31, 2018
Basic Sciences, Ocular Motor, Research
1 Comment
RESEARCH SUMMARY:  Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis. In this article, we are summarising recent research that has investigated the...
myelin repair microglia

Myelin Repair: Cellular Switch Identified?

MStranslate
July 24, 2018
Basic Sciences, Progressive MS, Remyelination, Research
1 Comment
PROGRESSIVE MULTIPLE SCLEROSIS AND MYELIN REPAIR We have seen an increasing number of powerful new treatments developed recently for relapsing remitting multiple sclerosis.  These treatments work in various...
  1. 7
  2. 8
  3. 9
  4. 10
  5. 11
  6. 12
  7. 13

Recent Posts

  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib

Recent Comments

  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026
  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date

Calendar

August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
« Jul    

Archives

Categories

Posts

  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.